11 – 20 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A Novel Topical PPAR 3 Agonist Induces PPAR 3 Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
(
- Contribution to journal › Article
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term effectiveness of vedolizumab in inflammatory bowel disease : a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
-
Mark
Prebiotics and synbiotics in ulcerative colitis
(
- Contribution to journal › Scientific review
-
Mark
Immunopathology of Inflammatory Bowel Disease
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Dairy products, dietary calcium, and risk of inflammatory bowel disease : Results from a European prospective cohort investigation
(
- Contribution to journal › Article
-
Mark
Telocytes, communicators in healthy stroma and relation to inflammation and fibrosis
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Exploring the microbiota of the gastrointestinal tract
2014)(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study
(
- Contribution to journal › Article
- 2008
-
Mark
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD
(
- Contribution to journal › Article